Role of new drug carbetocin for prevention of excessive bleeding after delivery.
Phase 4
- Conditions
- Health Condition 1: O721- Other immediate postpartum hemorrhage
- Registration Number
- CTRI/2024/02/062341
- Lead Sponsor
- Dr Laveena Gosai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients age >18 and < 40 years undergoing vaginal delivery or caesarean section
Exclusion Criteria
1. Coagulopathy
2. Drug hypersensitivity
3. Liver or kidney disease
4. Suspected placental pathology ( accreta,previa)
5. Placental abruption
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postpartum hemorrhage will be assessed after giving drugs for one hour post deliveryTimepoint: 1 hour post delivery
- Secondary Outcome Measures
Name Time Method Check for vitals and bleeding P/vTimepoint: 24 hours